Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Akebia Therapeutics, Inc. (AKBA) had Debt to Capital Ratio of 0.65 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$57.34M |
|
$6.11M |
|
$7.62M |
|
$49.71M |
|
$43.82M |
|
$13.51M |
|
$-7.40M |
|
$6.11M |
|
$6.11M |
|
$6.11M |
|
$6.11M |
|
$6.11M |
|
$6.11M |
|
$13.51M |
|
$13.83M |
|
235.50M |
|
241.60M |
|
$0.03 |
|
$0.03 |
|
| Balance Sheet Financials | |
$203.78M |
|
$1.90M |
|
$106.40M |
|
$310.19M |
|
$91.23M |
|
$46.51M |
|
$194.38M |
|
$285.60M |
|
$24.58M |
|
$-34.46M |
|
$24.58M |
|
261.64M |
|
| Cash Flow Statement Financials | |
$-13.59M |
|
$0.15M |
|
$74.94M |
|
$53.55M |
|
$115.06M |
|
$61.51M |
|
$2.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.23 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.65 |
1.89 |
|
86.70% |
|
23.57% |
|
23.57% |
|
-- |
|
10.66% |
|
10.66% |
|
$-13.43M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.39 |
|
0.93 |
|
96.60 |
|
24.86% |
|
-17.73% |
|
1.97% |
|
8.60% |
|
$0.09 |
|
$-0.06 |
|
$-0.06 |
|